1-4 of 4
Christian J. Chatelain, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture

Hélène Haguet, MSc, Jonathan Douxfils, Christian J. Chatelain, MD, Carlos Graux, Francois Mullier, PharmD, Jean-Michel Dogné
Journal: Blood
Blood (2017) 130 (Supplement 1): 1591.
https://doi.org/10.1182/blood.V130.Suppl_1.1591.1591
Published: 2017
Journal Articles

In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions

Hélène Haguet, MSc, Jonathan Douxfils, Christian J. Chatelain, MD, Carlos Graux, Francois Mullier, PharmD, Jean-Michel Dogné
Journal: Blood
Blood (2017) 130 (Supplement 1): 1592.
https://doi.org/10.1182/blood.V130.Suppl_1.1592.1592
Published: 2017
Journal Articles

Transfer of Multidrug Resistance Among Acute Myeloid Leukemia Cells Via Extracellular Vesicles and Their Micrornas Cargo

Céline Bouvy, PhDStudent, Adeline Wannez, PhDStudent, Christian J. Chatelain, MD, Jean-Michel Dogné, Pharm.D PhD
Journal: Blood
Blood (2016) 128 (22): 2864.
https://doi.org/10.1182/blood.V128.22.2864.2864
Published: 2016
Journal Articles

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Jonathan Douxfils, Pharm.D PhDCandidate, Hélène Haguet, MSc, Christian J. Chatelain, MD, Carlos Graux, MDPhD, Jean-Michel Dogné, Pharm.D PhD
Journal: Blood
Blood (2015) 126 (23): 2785.
https://doi.org/10.1182/blood.V126.23.2785.2785
Published: 2015